Status:
UNKNOWN
Cannabidiol Oil Extract for Prevention of Postoperative Nausea and Vomiting
Lead Sponsor:
The University of The West Indies
Conditions:
Postoperative Nausea and Vomiting
Eligibility:
FEMALE
18-65 years
Phase:
EARLY_PHASE1
Brief Summary
Cannabidiol oil has been shown to be effective in treating chemotherapy induced nausea and vomiting, but there is limited information on its usefulness in nausea and vomiting that can occur after surg...
Detailed Description
The overall aim of this study is to evaluate the effect of Cannabidiol oil on postoperative nausea and vomiting in elective gynaecological surgical patients undergoing general anaesthesia at the Unive...
Eligibility Criteria
Inclusion
- All patients for elective gynaecological surgical procedures under general anaesthesia at the Main operating theatre, UHWI between the ages of 18-65 years.
Exclusion
- Reported allergy to cannabis/CBD by products, coconut oil, peppermint oil
- Patients \< 18 years
- Patients experiencing disease related nausea and vomiting
- Patients with psychological/psychiatric illnesses which prevent communication or impairs their ability to give informed consent
- Patients undergoing regional anaesthesia
- Contraindication to medicinal cannabis such as unstable cardiovascular disease, substance use disorder, or significant mental health disorder
- Cannabis use within 30 days of surgery
- Pregnancy
Key Trial Info
Start Date :
September 21 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 29 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06137027
Start Date
September 21 2023
End Date
February 29 2024
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of the West Indies
Kingston, Jamaica